New England Biolabs UK Ltd CST - Cell Signaling Technology Biohelix Corp
Search:
Product CatalogueNew from New England Biolabs...Special OffersTechnical ResourcesContact UsMy Account
home > Product Catalogue > Cell Signaling Technology > Tyrosine Kinase Adaptors > CrkII Antibody

CrkII Antibody #3492

Catalog # Size & Concentration Price(£) Qty
3492S 100 ul (10 western blots) 172.00
Please contact us for bulks/custom orders/drug discovery applications

Applications Reactivity Sensitivity MW (kDa) Source
W H M Endogenous 42 Rabbit

Applications Key:  W=Western Blotting
Reactivity Key:  H=Human  M=Mouse
Species cross-reactivity is determined by Western blot.

Protocols

Specificity / Sensitivity

CrkII Antibody detects endogenous levels of CrkII protein. This antibody does not cross-react with related proteins.

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Trp169 of human CrkII protein. Antibodies are purified by protein A and peptide affinity chromatography.

Western Blotting

Western Blotting

Western blot analysis of extracts from HepG2 cells (human hepatocellular carcinoma) and NIH/3T3 cells (mouse fibroblasts), using CrkII Antibody.

Background

CrkII, a cellular homologue of v-Crk, belongs to a family of adaptor proteins with an SH2-SH3-SH3 domain structure that transmits signals from tyrosine kinases (1). The primary function of Crk is to recruit cytoplasmic proteins in the vicinity of tyrosine kinases through SH2-phospho-tyrosine interaction. Thus, the output from Crk depends on the SH3-binding proteins, which include the C3G and Sos guanine nucleotide exchange proteins, Abl tyrosine kinase, DOCK180 and some STE20-related kinases. The variety of Crk-binding proteins indicates the pleiotropic function of Crk (2). The two CrkII SH3 domains are separated by a 54 amino acid linker region, which is highly conserved in Xenopus, chicken and mammalian CrkII proteins (3). Tyrosine 221 in this region is phosphorylated by the Abl tyrosine kinase (4), IGF-I receptor (5) and EGF receptor (6). Once Tyr221 is phosphorylated, CrkII undergoes a change in intramolecular folding and SH2-pTyr interaction, which causes rapid dissociation of CrkII from the tyrosine kinase complex (3).

  1. Zvara, A. et al. (2001) Oncogene 20, 951-961.
  2. Kiyokawa, E. et al. (1997) Crit. Rev. Oncog. 8, 329-342.
  3. Rosen, S. K. et al. (1995) Nature 374, 477-479.
  4. Amoui, M. and Miller, W.T. (2000) Cell. Signal. 12, 637-643.
  5. Koval, A. P. et al. (1998) Biochem. J. 330, 923-932.
  6. Hashimoto, Y. et al. (1998) J. Biol. Chem. 273, 17186-17191.
Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products


This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.